Explore the landscape of KRAS+ NSCLC treatment in the 2022 Targeted Therapies Forum with Dr. Jia Luo, a distinguished Medical Oncologist from Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard. In this enlightening video, Dr. Luo delves into the prevalence of KRAS+ NSCLC and charts the transformative journey of its treatments over the years.
Special thanks to our invaluable sponsors for their unwavering support: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.
Stay informed with the latest in oncology research and insights. Visit http://cancerGRACE.org/ and become an active part of our thriving community at https://cancergrace.org/forum.